Novel Approaches to the Development of Antimigraine Drugs: A Focus on 5-HT2A Receptor Antagonists
- Авторы: Spasov A.1,2, Yakovlev D.1,2, Brigadirova A.1,2, Maltsev D.1,2, Agatsarskaya Y.1,2
-
Учреждения:
- Volgograd Medical Research Center
- Volgograd State Medical University
- Выпуск: Том 45, № 2 (2019)
- Страницы: 76-88
- Раздел: Review Article
- URL: https://journals.rcsi.science/1068-1620/article/view/229167
- DOI: https://doi.org/10.1134/S1068162019020146
- ID: 229167
Цитировать
Аннотация
The review is devoted to promising directions of the search for chemical compounds which can be used as the basis for the development of new drugs for migraine treatment. It considers promising biological targets, whose effects are capable of eliminating the manifestations of acute migraine attacks, and also indicates the main existing developments in the form of chemical compounds and drug prototypes interacting with these targets, including those that will soon enter or are at the stage of clinical trials. In particular, preclinical and clinical data on compounds whose effects are determined by the influence on the calcitonin gene-related peptide (CGRP) receptors, serotonin 5-HT2A and 5-HT1F receptors, NO-synthase, orexin and glutamate receptors, are discussed. The review focuses on the description of 5-HT2A receptors as a promising target for the development of novel antimigraine drugs. Information about the structural features of this serotonin receptor subtype, the localization and functions is given; also it involves the pharmacological capabilities of new substances affecting 5-HT2A receptors. The final part of the review is devoted to new trends in the search for 5-HT2A antagonists among compounds synthesized based on a serotonin bioisostere, benzimidazole.
Ключевые слова
Об авторах
A. Spasov
Volgograd Medical Research Center; Volgograd State Medical University
Email: a.brigadirova@gmail.com
Россия, Volgograd, 400131; Volgograd, 400131
D. Yakovlev
Volgograd Medical Research Center; Volgograd State Medical University
Email: a.brigadirova@gmail.com
Россия, Volgograd, 400131; Volgograd, 400131
A. Brigadirova
Volgograd Medical Research Center; Volgograd State Medical University
Автор, ответственный за переписку.
Email: a.brigadirova@gmail.com
Россия, Volgograd, 400131; Volgograd, 400131
D. Maltsev
Volgograd Medical Research Center; Volgograd State Medical University
Email: a.brigadirova@gmail.com
Россия, Volgograd, 400131; Volgograd, 400131
Y. Agatsarskaya
Volgograd Medical Research Center; Volgograd State Medical University
Email: a.brigadirova@gmail.com
Россия, Volgograd, 400131; Volgograd, 400131